BrainJuicer chief executive nets £1.75m from share sale
He continues to own 4.5m shares, or 36.22% of the company – a stake worth more than £11m at the current share price.
Chief financial officer James Geddes has also sold shares, 75,000 of them, worth £187,500.
In a statement the firm said the sales were prompted by “the level of instutional demand in the company’s shares”.
Unilever, which had been an investor in the business since 2003, recently sold off the last of its BrainJuicer shares.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments